Home › Head and Neck Squamous Cell Carcinoma › Indiana › Fort Wayne
Head and Neck Squamous Cell Carcinoma clinical trials in Fort Wayne, IN
4 studies for Head and Neck Squamous Cell Carcinoma are looking for participants at sites in and around Fort Wayne (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Phase 1 of CTX-8371 in Patients With Advanced Malignancies
RecruitingPhase 1
- Fort Wayne Medical Oncology and Hematology, Fort Wayne
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
RecruitingPhase 1
- Fort Wayne Medical Oncology and Hematology, Inc, Fort Wayne
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
RecruitingPhase 1
- Fort Wayne Medical Oncology and Hematology, Inc /ID# 232593, Fort Wayne
A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma
RecruitingPhase 3
- GSK Investigational Site, Fort Wayne
Head and Neck Squamous Cell Carcinoma trials in other cities
- Houston, TX47 studies
- Los Angeles, CA42 studies
- Boston, MA40 studies
- New York City, NY39 studies
- Nashville, TN39 studies
- St. Louis, MO28 studies
- Arlington, VA26 studies
- Philadelphia, PA26 studies
- Chicago, IL26 studies
- Atlanta, GA24 studies
- San Antonio, TX22 studies
- New Haven, CT22 studies
Other studies in Fort Wayne
- Non-Small Cell Lung Cancer17 studies
- Ovarian Cancer8 studies
- Cancer (all types)7 studies
- Chronic Lymphocytic Leukemia7 studies
- Breast Cancer7 studies
- Lung Cancer6 studies
- Metastatic Cancer6 studies
- Endometrial Cancer5 studies
- Melanoma4 studies
- Triple-Negative Breast Cancer4 studies
- Colorectal Cancer4 studies
- Multiple Myeloma4 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.